医药创新系统中的“R&D-大服务”联动:基于两个一类新药创新的研究  

Linkages between R&D and Service in Pharmaceutical Innovation System:Based on the Study of Two New Drugs Innovation

作　　者：赵远亮[1] 周寄中[1] 许治[1] 

机构地区：[1]中国科学院研究生院管理学院,北京100049

出　　处：《中国软科学》2008年第8期43-51,共9页China Soft Science

基　　金：国家自然科学基金资助项目(项目编号:70773110)

摘　　要：本文通过两个新药创新案例剖析了医药创新系统中政府、科研、大学、企业等要素的联动关系,其本质上也即"R&D-大服务"的联动。在"R&D-大服务"联动中,当创新要素完备且充分联动时,创新系统发挥较好的功能,创新绩效较高;反之,亦反之。上述联动也存在于企业创新系统中,联动作用的发挥决定了企业创新的绩效。Through analyzing innovation of two new drugs, this paper anatomizes the linkage among the various actors （government, research institutes, university and enterprises） in the pharmaceutical innovation system （PIS）. This linkage is in essence the linkage of ＂R＆D - Services＂. The research indicates when the main body factors link with each other fully the PIS would show good functions of learning, cooperation, innovation and opening. This linkage also exists in pharmaceutical enterprise, which decides the performance of the company innovation system.

关 键 词：医药创新 R&D 大服务 联动 

分 类 号：C93[经济管理—管理学]